Screener
King Pharmaceuticals KG % of Total
% of Total at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:OtherInvestmentsPercentOfTotal.
The source filing: King Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 8:49 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054606
| Line item | June 30, 2026 / Fair value | June 30, 2026 / % of Total | December 31, 2025 / Fair Value | December 31, 2025 / % of Total |
|---|---|---|---|---|
| Private equity funds(1) | $33,491 | 19.3% | $31,732 | 18.3% |
| Privately held equity investments(1) | 9,485 | 5.5% | 9,248 | 5.4% |
| Private credit investments(1) | 307 | 0.2% | 192 | 0.1% |
| Equity method investments with fair value option elected | 76,870 | 44.3% | 78,911 | 45.5% |
| Investments in direct lending entities | 53,127 | 30.7% | 53,275 | 30.7% |
| Total other investments at fair value | $173,280 | 100.0% | $173,358 | 100.0% |
Item 1. Financial Statements
FAQ
- What is King Pharmaceuticals's % of total?
- King Pharmaceuticals (KG) reported % of total of $1 in Q2 2026.
- What does % of total mean?
- % of Total as reported by Kestrel Group Ltd.
Ask your AI about King Pharmaceuticals's % of total.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude